Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D C Case

Showing results (41-50 of 48) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 48 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1983
Improved prognosis of diffuse histiocytic and undifferentiated lymphoma by use of high dose methotrexate alternating with standard agents (M-BACOD)A T Skarin, G P Canellos, D S Rosenthal, et al.
Cancer Treatment Reports|November 1, 1984
Combination chemotherapy for advanced non-Hodgkin's lymphomas other than diffuse histiocytic or undifferentiated histologiesK C Anderson, A T Skarin, D S Rosenthal, et al.
Investigational New Drugs|January 1, 1987
Interferon alfa-2b/melphalan/prednisone in previously untreated patients with multiple myeloma: a phase I-II trialM R Cooper, A Fefer, J Thompson, et al.
Seminars in Hematology|April 1, 1987
The m-BACOD combination chemotherapy regimen in the treatment of diffuse large cell lymphomaG P Canellos, A T Skarin, M M Klatt, et al.
Blood|January 25, 1992
Cytarabine plus idarubicin or daunorubicin as induction and consolidation therapy for previously untreated adult patients with acute myeloid leukemiaP H Wiernik, P L Banks, D C Case, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1991
Multicenter clinical trial of mitoxantrone in non-Hodgkin's lymphoma and Hodgkin's diseaseR T Silver, D C Case, R H Wheeler, et al.
Journal of the National Cancer Institute|May 19, 1993
Recombinant human erythropoietin therapy for anemic cancer patients on combination chemotherapyD C Case, R M Bukowski, R W Carey, et al.
The Cancer Journal From Scientific American|November 1, 1995
Recombinant human erythropoietin therapy for anemic cancer patients receiving cisplatin chemotherapyD H Henry, B J Brooks, D C Case, et al.
Pageof 5

Showing results (41-50 of 48) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1983
Improved prognosis of diffuse histiocytic and undifferentiated lymphoma by use of high dose methotrexate alternating with standard agents (M-BACOD)A T Skarin, G P Canellos, D S Rosenthal, et al.
Cancer Treatment Reports|November 1, 1984
Combination chemotherapy for advanced non-Hodgkin's lymphomas other than diffuse histiocytic or undifferentiated histologiesK C Anderson, A T Skarin, D S Rosenthal, et al.
Investigational New Drugs|January 1, 1987
Interferon alfa-2b/melphalan/prednisone in previously untreated patients with multiple myeloma: a phase I-II trialM R Cooper, A Fefer, J Thompson, et al.
Seminars in Hematology|April 1, 1987
The m-BACOD combination chemotherapy regimen in the treatment of diffuse large cell lymphomaG P Canellos, A T Skarin, M M Klatt, et al.
Blood|January 25, 1992
Cytarabine plus idarubicin or daunorubicin as induction and consolidation therapy for previously untreated adult patients with acute myeloid leukemiaP H Wiernik, P L Banks, D C Case, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1991
Multicenter clinical trial of mitoxantrone in non-Hodgkin's lymphoma and Hodgkin's diseaseR T Silver, D C Case, R H Wheeler, et al.
Journal of the National Cancer Institute|May 19, 1993
Recombinant human erythropoietin therapy for anemic cancer patients on combination chemotherapyD C Case, R M Bukowski, R W Carey, et al.
The Cancer Journal From Scientific American|November 1, 1995
Recombinant human erythropoietin therapy for anemic cancer patients receiving cisplatin chemotherapyD H Henry, B J Brooks, D C Case, et al.
Pageof 5